No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches.
Saved in:
| Title: | No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches. |
|---|---|
| Authors: | Nguyen D; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Miao X; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Taskar K; GlaxoSmithKline, Ware, UK., Magee M; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Gorycki P; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Moore K; Allucent, Cary, North Carolina, USA., Tai G; GlaxoSmithKline, Collegeville, Pennsylvania, USA. |
| Source: | Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Aug; Vol. 12 (4), pp. e1238. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 101626369 Publication Model: Print Cited Medium: Internet ISSN: 2052-1707 (Electronic) Linking ISSN: 20521707 NLM ISO Abbreviation: Pharmacol Res Perspect Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
